6061 - 6070 of 7730 Results
Title
Year
- Adaptive preconditioning in neurological diseases – therapeutic insights from proteostatic perturbations2016RESTRICTEDTitle: Adaptive preconditioning in neurological diseases – therapeutic insights from proteostatic perturbationsJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1648Issue #:Start Page: 603End Page: 616Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.brainres.2016.02.033Best OA location URL: https://doi.org/10.1016/j.brainres.2016.02.033Citation Count: 39
-
RESTRICTEDTitle: Arm swing as a potential new prodromal marker of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 10Start Page: 1527End Page: 1534Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26720Best OA location URL: https://europepmc.org/articles/pmc5053872?pdf=renderCitation Count: 144
- Association ofGBAMutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease2016RESTRICTEDTitle: Association ofGBAMutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 73Issue #: 10Start Page: 1217End Page: 1217Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2016.2245Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2546252/noi160057.pdfCitation Count: 188
- Atrophy and structural covariance of the cholinergic basal forebrain in primary progressive aphasia2016RESTRICTEDTitle: Atrophy and structural covariance of the cholinergic basal forebrain in primary progressive aphasiaJournal Name: CortexPublisher: Elsevier BVVol: 83Issue #:Start Page: 124End Page: 135Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cortex.2016.07.004Best OA location URL: https://doi.org/10.1016/j.cortex.2016.07.004Citation Count: 20
- Effects of a higher dose of near-infrared light on clinical signs and neuroprotection in a monkey model of Parkinson's disease2016RESTRICTEDTitle: Effects of a higher dose of near-infrared light on clinical signs and neuroprotection in a monkey model of Parkinson's diseaseJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1648Issue #:Start Page: 19End Page: 26Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2016.07.005Citation Count: 30
- Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrum2016RESTRICTEDTitle: Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrumJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 46Issue #:Start Page: 32End Page: 42Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2016.06.003Best OA location URL: https://europepmc.org/articles/pmc5018437?pdf=renderCitation Count: 21
-
RESTRICTEDTitle: Gene therapy to target ER stress in brain diseasesJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1648Issue #:Start Page: 561End Page: 570Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2016.04.064Citation Count: 31
-
RESTRICTEDTitle: Injury to the nervous system: A look into the ERJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1648Issue #:Start Page: 617End Page: 625Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2016.04.053Citation Count: 24
-
RESTRICTEDTitle: Longitudinal changes in CSF alpha‐synuclein species reflect Parkinson's disease progressionJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 10Start Page: 1535End Page: 1542Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26754Citation Count: 121
- LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: current perspectives2016RESTRICTEDTitle: LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: current perspectivesJournal Name: Clinical Pharmacology: Advances and ApplicationsPublisher: Informa UK LimitedVol: Volume 8Issue #:Start Page: 177End Page: 189Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.2147/cpaa.s102191Best OA location URL: https://www.dovepress.com/getfile.php?fileID=33080Citation Count: 41